Teon Therapeutics Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$30M
- Investors
-
6
Teon Therapeutics General Information
Description
Developer of single-target small molecules designed to restore antitumor immunity and suppress cancer cell proliferation. The company's created molecules combine treatments including metabolic checkpoint inhibitors and GPCR immune checkpoint inhibitors to unleash the full potential of immunotherapies by reinvigorating anti-cancer immunity, enabling healthcare professionals to improve long-term outcomes for more patients with cancer.
Contact Information
Website
www.teontherapeutics.comCorporate Office
- 555 Twin Dolphin Drive
- Suite 120
- Redwood City, CA 94065
- United States
Corporate Office
- 555 Twin Dolphin Drive
- Suite 120
- Redwood City, CA 94065
- United States
Teon Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 23-Feb-2021 | $30M | Completed | Clinical Trials - Phase 1 | ||
| 2. Debt - PPP | 15-Apr-2020 | Completed | Clinical Trials - Phase 1 | |||
| 1. Seed Round | 24-Jan-2019 | $5M | $5M | Completed | Clinical Trials - Phase 1 |
Teon Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Series AA | 317,159 | $0.000100 | 6% | $1.58 | $1.58 | 1x | $1.58 | 0.87% |
| Seed | 4,679,895 | $0.000100 | 6% | $1.07 | $1.07 | 1x | $1.07 | 12.87% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Teon Therapeutics Comparisons
Industry
Financing
Details
Teon Therapeutics Competitors (2)
One of Teon Therapeutics’s 2 competitors is CytomX Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CytomX Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Precigen | Formerly VC-backed | Germantown, MD |
Teon Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Teon Therapeutics Patents
Teon Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026035860-A1 | Formulations of adenosine receptor antagonist | Pending | 07-Aug-2024 | ||
| US-20240140979-A1 | Heterocyclic inhibitors of cd73 for treatment of disease | Inactive | 03-Oct-2022 | ||
| US-20240140980-A1 | Heterocyclic inhibitors of cd73 for treatment of disease | Inactive | 03-Oct-2022 | ||
| WO-2024076872-A1 | Heterocyclic inhibitors of cd73 for treatment of disease | Inactive | 03-Oct-2022 | ||
| WO-2024076873-A1 | Heterocyclic inhibitors of cd73 for treatment of disease | Inactive | 03-Oct-2022 | C07H19/23 |
Teon Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Teon Therapeutics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Lifespan Investments | Venture Capital | Minority | ||
| Oceanpine Healthcare Fund | Growth/Expansion | Minority | ||
| Oriza Ventures | Venture Capital | Minority | ||
| Kaitai Capital | Venture Capital | Minority | ||
| Northern Light Venture Capital | Venture Capital | Minority |
Teon Therapeutics FAQs
-
When was Teon Therapeutics founded?
Teon Therapeutics was founded in 2017.
-
Where is Teon Therapeutics headquartered?
Teon Therapeutics is headquartered in Redwood City, CA.
-
What is the size of Teon Therapeutics?
Teon Therapeutics has 9 total employees.
-
What industry is Teon Therapeutics in?
Teon Therapeutics’s primary industry is Drug Discovery.
-
Is Teon Therapeutics a private or public company?
Teon Therapeutics is a Private company.
-
What is the current valuation of Teon Therapeutics?
The current valuation of Teon Therapeutics is .
-
What is Teon Therapeutics’s current revenue?
The current revenue for Teon Therapeutics is .
-
How much funding has Teon Therapeutics raised over time?
Teon Therapeutics has raised $35M.
-
Who are Teon Therapeutics’s investors?
Lifespan Investments, Oceanpine Healthcare Fund, Oriza Ventures, Kaitai Capital, and Northern Light Venture Capital are 5 of 6 investors who have invested in Teon Therapeutics.
-
Who are Teon Therapeutics’s competitors?
CytomX Therapeutics and Precigen are competitors of Teon Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
